| PERIOD ENDING | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | 28-Sep-08 | | Total Revenue | 100,341 | 98,315 | 93,940 | 29,215 | | Cost of Revenue | 93,664 | 70,552 | 67,127 | (12,795) | | | Gross Profit | 6,677 | 27,763 | 26,813 | 42,010 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 8,412 | 29,730 | 29,504 | 50,569 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 214 | 207 | 206 | 206 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,949) | (2,174) | (2,897) | (8,765) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 14 | 43 | 115 | 137 | | Earnings Before Interest And Taxes | (1,935) | (2,131) | (2,782) | (8,628) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (1,935) | (2,131) | (2,782) | (8,628) | | Income Tax Expense | (5,946) |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,011 | (2,131) | (2,782) | (8,628) | | | Non-recurring Events | | Discontinued Operations | (2,985) | 2,985 | 3,071 | 5,009 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,026 | 854 | 289 | (3,619) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,026 | $854 | $289 | ($3,619) |
|
0.02% Nasdaq 
0.33%
Income Statement
